Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhu's Wenban and Qushi Formulas for Carotid Unstable Plaque
NCT05622877Phase 1Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- May 2023
- Primary completion
- Jan 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of wendan decoction in carotid atheroma (CAS) (3 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Changes in carotid artery unstable plaque at 6 months. Status: unknown.
02
Drugs
wendan decoction
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT05622877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05622877.